1
|
Kelley JM, Rathinasamy V, Elliott TP, Rawlin G, Beddoe T, Stevenson MA, Spithill TW. Determination of the prevalence and intensity of Fasciola hepatica infection in dairy cattle from six irrigation regions of Victoria, South-eastern Australia, further identifying significant triclabendazole resistance on three properties. Vet Parasitol 2019; 277:109019. [PMID: 31918044 DOI: 10.1016/j.vetpar.2019.109019] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2019] [Revised: 12/19/2019] [Accepted: 12/20/2019] [Indexed: 11/19/2022]
Abstract
Fasciola hepatica (liver fluke) is a widespread parasite infection of livestock in Victoria, South-eastern Australia, where high rainfall and a mild climate is suitable for the main intermediate host Austropeplea tomentosa. The aims of this study were to quantify the prevalence and intensity of F. hepatica in dairy cattle in the irrigated dairy regions of Victoria and determine if triclabendazole resistance was present in infected herds. Cattle in 83 herds from the following six irrigation regions were tested for F. hepatica: Macalister Irrigation District (MID), Upper Murray (UM), Murray Valley (MV), Central Goulburn (CG), Torrumbarry (TIA) and Loddon Valley (LV). Twenty cattle from each herd were tested using the F. hepatica faecal egg count (FEC) as well as the coproantigen ELISA (cELISA). The mean individual animal true prevalence of F. hepatica across all regions was 39 % (95 % credible interval [CrI] 27%-51%) by FEC and 39 % (95 % CrI 27%-50%) by cELISA with the highest true prevalence (75-80 %) found in the MID. Our results show that 46 % of the herds that took part in this study were likely to experience fluke-associated production losses, based on observations that herd productivity is impaired when the true within-herd prevalence is > 25 %. Using the FEC and cELISA reduction tests, triclabendazole resistance was assessed on 3 herds in total (2 from the 83 in the study; and 1 separate herd that did not take part in the prevalence study) and resistance was confirmed in all 3 herds. This study has confirmed that F. hepatica is endemic in several dairy regions in Victoria: triclabendazole resistance may be contributing to the high prevalence in some herds. From our analysis, we estimate that the state-wide economic loss associated with fasciolosis is in the order of AUD 129 million (range AUD 38-193 million) per year or about AUD 50,000 (range AUD 15,000-75,000) per herd per year.
Collapse
Affiliation(s)
- Jane M Kelley
- Department of Animal, Plant and Soil Sciences, Centre for AgriBioscience, La Trobe University, Bundoora Victoria 3083, Australia
| | - Vignesh Rathinasamy
- Department of Animal, Plant and Soil Sciences, Centre for AgriBioscience, La Trobe University, Bundoora Victoria 3083, Australia
| | | | - Grant Rawlin
- Department of Jobs, Precincts and Regions, Centre for AgriBioscience, La Trobe University, Bundoora Victoria 3083, Australia
| | - Travis Beddoe
- Department of Animal, Plant and Soil Sciences, Centre for AgriBioscience, La Trobe University, Bundoora Victoria 3083, Australia
| | - Mark A Stevenson
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville Victoria 3010, Australia
| | - Terry W Spithill
- Department of Animal, Plant and Soil Sciences, Centre for AgriBioscience, La Trobe University, Bundoora Victoria 3083, Australia.
| |
Collapse
|
2
|
Hodgkinson JE, Cwiklinski K, Beesley N, Hartley C, Allen K, Williams DJL. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones. Parasit Vectors 2018; 11:363. [PMID: 29941045 PMCID: PMC6020221 DOI: 10.1186/s13071-018-2952-z] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2018] [Accepted: 06/13/2018] [Indexed: 11/10/2022] Open
Abstract
Background Fasciola hepatica is of worldwide significance, impacting on the health, welfare and productivity of livestock and regarded by WHO as a re-emerging zoonosis. Triclabendazole (TCBZ), the drug of choice for controlling acute fasciolosis in livestock, is also the drug used to treat human infections. However TCBZ-resistance is now considered a major threat to the effective control of F. hepatica. It has yet to be demonstrated whether F. hepatica undergoes a genetic clonal expansion in the snail intermediate host, Galba truncatula, and to what extent amplification of genotypes within the snail facilitates accumulation of drug resistant parasites. Little is known about genotypic and phenotypic variation within and between F. hepatica isolates. Results Six clonal isolates of F. hepatica (3× triclabendazole-resistant, TCBZ-R and 3× triclabendazole-susceptible, TCBZ-S) were generated. Snails infected with one miracidium started to shed cercariae 42–56 days post-infection and shed repeatedly up to a maximum of 11 times. A maximum of 884 cercariae were shed by one clonally-infected snail (FhLivS1) at a single time point, with > 3000 clonal metacercariae shed over its lifetime. Following experimental infection all 12 sheep were FEC positive at the time of TCBZ treatment. Sheep infected with one of three putative TCBZ-S clones and treated with TCBZ had no parasites in the liver at post-mortem, whilst sheep each infected with putative TCBZ-R isolates had 35–165 adult fluke at post-mortem, despite TCBZ treatment. All six untreated control animals had between 15–127 parasites. A single multi-locus genotype was reported for every fluke from each of the six clonal isolates. Adult F. hepatica showed considerable variation in weight, ranging from 20–280 mg, with variation in weight evident within and amongst clonal isolates. Conclusions A genetic clonal expansion occurs within G. truncatula, highlighting the potential for amplification of drug resistant genotypes of F. hepatica. Variation in the weight of parasites within and between clonal isolates and when comparing isolates that are either susceptible or resistant to TCBZ represent inherent variation in liver fluke and cannot be attributed to their resistance or susceptibility traits.
Collapse
Affiliation(s)
- Jane E Hodgkinson
- Veterinary Parasitology, Dept Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, L69 7ZJ, UK.
| | - Krystyna Cwiklinski
- Veterinary Parasitology, Dept Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, L69 7ZJ, UK.,School of Biological Sciences, Medical Biology Centre, Queen's University Belfast, Belfast, BT9 7BL, UK
| | - Nicola Beesley
- Veterinary Parasitology, Dept Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, L69 7ZJ, UK
| | - Catherine Hartley
- Veterinary Parasitology, Dept Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, L69 7ZJ, UK
| | - Katherine Allen
- Veterinary Parasitology, Dept Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, L69 7ZJ, UK
| | - Diana J L Williams
- Veterinary Parasitology, Dept Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, L69 7ZJ, UK
| |
Collapse
|
3
|
Brockwell YM, Elliott TP, Anderson GR, Stanton R, Spithill TW, Sangster NC. Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle. Int J Parasitol Drugs Drug Resist 2013; 4:48-54. [PMID: 24596668 PMCID: PMC3940233 DOI: 10.1016/j.ijpddr.2013.11.005] [Citation(s) in RCA: 69] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/01/2013] [Revised: 11/26/2013] [Accepted: 11/27/2013] [Indexed: 11/27/2022]
Abstract
Triclabendazole resistant F. hepatica is confirmed in infected Australian cattle. Resistance was observed on four beef properties and one dairy property. Live drug resistant adult flukes were recovered from cattle after treatment. A coproantigen reduction test was used to identify resistance. We describe a method suitable for post-treatment analysis of fluke infection.
Triclabendazole (TCBZ) is the drug of choice for Fasciola hepatica control and reports of F. hepatica resistant to this drug from a wide range of geographic regions are very concerning. This study investigated the presence of TCBZ resistance in F. hepatica in naturally infected Australian beef and dairy cattle herds and evaluated methods of measuring the levels of resistance. Faecal egg count and coproantigen reduction tests (FECRT and CRT, respectively) were conducted on 6 South-eastern Australian beef properties and one dairy property where treatment failure by triclabendazole (TCBZ) was suspected. The CRT was conducted on an additional beef property. On each property 15 animals were treated with an oral preparation of TCBZ at the recommended dose and 15 animals remained as untreated controls. Fluke eggs in faeces were counted and coproantigen levels were measured before treatment and 21 days after treatment and in the untreated control animals. These data were evaluated using three different methods to calculate % reductions compared with controls. Resistance (<90% reduction) was detected on the dairy property using both FEC and CRT, and on 3/6 beef properties using FECRT and 4/7 beef properties using CRT. Using the FECRT, reductions of 6.1–14.1% were observed in dairy cattle and 25.9–65.5% in beef cattle. Using the CRT, reductions of 0.4–7.6% were observed in dairy cattle and 27.0–69.5% in beef cattle. Live flukes were recovered at slaughter following TCBZ treatment of 6 cattle from 3 of the beef properties, confirming the TCBZ resistance status of F. hepatica in these cattle. This is the first report of F. hepatica resistant to TCBZ in cattle in Australia and the results suggest that resistance is widespread in the South-eastern region. The CRT is shown to be a robust alternative to the FECRT for evaluation of TCBZ resistance in F. hepatica in cattle.
Collapse
Affiliation(s)
- Yvette M Brockwell
- School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, N.S.W. 2678, Australia
| | - Timothy P Elliott
- Department of Agricultural Sciences and Centre for AgriBioscience, La Trobe University, Bundoora, Vic 3083, Australia
| | - Glenn R Anderson
- School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, N.S.W. 2678, Australia ; Virbac (Australia) Pty Ltd., Milperra, N.S.W. 2214, Australia
| | - Rex Stanton
- E.H. Graham Centre, Charles Sturt University, Wagga Wagga, N.S.W. 2678, Australia
| | - Terry W Spithill
- School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, N.S.W. 2678, Australia ; Department of Agricultural Sciences and Centre for AgriBioscience, La Trobe University, Bundoora, Vic 3083, Australia
| | - Nicholas C Sangster
- School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, N.S.W. 2678, Australia
| |
Collapse
|
4
|
Elliott T, Muller A, Brockwell Y, Murphy N, Grillo V, Toet HM, Anderson G, Sangster N, Spithill TW. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia. Vet Parasitol 2013; 200:90-6. [PMID: 24360656 DOI: 10.1016/j.vetpar.2013.11.019] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2013] [Revised: 11/12/2013] [Accepted: 11/19/2013] [Indexed: 11/29/2022]
Abstract
In recent years, the global incidence of Fasciola hepatica (liver fluke) infections exhibiting resistance to triclabendazole (TCBZ) has increased, resulting in increased economic losses for livestock producers and threatening future control. The development of TCBZ resistance and the worldwide discovery of F. hepatica population diversity has emphasized the need to further understand the genetic structure of drug susceptible and resistant Fasciola populations within Australia. In this study, the genetic diversity of liver flukes was estimated by sequencing mitochondrial DNA (mtDNA) encoding the NAD1 (530 bp) and COX1 (420 bp) genes of 208 liver flukes (F. hepatica) collected from three populations: field isolates obtained from abattoirs from New South Wales (NSW) and Victoria (Vic); three TCBZ-resistant fluke populations from NSW and Victoria; and the well-established TCBZ-susceptible Sunny Corner laboratory isolate. Overall nucleotide diversity for all flukes analysed of 0.00516 and 0.00336 was estimated for the NAD1 and COX1 genes respectively. Eighteen distinct haplotypes were established for the NAD1 gene and six haplotypes for the COX1 gene, resulting in haplotype diversity levels of 0.832 and 0.482, respectively. One field isolate showed a similar low level of haplotype diversity as seen in the Sunny Corner laboratory isolate. Analysis of TCBZ-resistant infrapopulations from 3 individual cattle grazing one property revealed considerable sequence parasite diversity between cattle. Analysis of parasite TCBZ-resistant infrapopulations from sheep and cattle revealed haplotypes unique to each host, but no significant difference between parasite populations. Fst analysis of fluke populations revealed little differentiation between the resistant and field populations. This study has revealed a high level of diversity in field and drug resistant flukes in South-Eastern Australia.
Collapse
Affiliation(s)
- T Elliott
- Department of Agricultural Sciences and Centre for AgriBioscience, La Trobe University, Bundoora, VIC, Australia
| | - A Muller
- School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia
| | - Y Brockwell
- School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia
| | - N Murphy
- Department of Genetics, La Trobe University, Bundoora, VIC, Australia
| | - V Grillo
- School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia; Australian Wildlife Health Network, Taronga Zoo, Sydney, NSW, Australia
| | - H M Toet
- Department of Agricultural Sciences and Centre for AgriBioscience, La Trobe University, Bundoora, VIC, Australia
| | - G Anderson
- Virbac (Australia) Pty Ltd., Australia, Milperra, NSW, Australia
| | - N Sangster
- School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia
| | - T W Spithill
- Department of Agricultural Sciences and Centre for AgriBioscience, La Trobe University, Bundoora, VIC, Australia; School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia.
| |
Collapse
|